Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

By Tami Luhby, CNN

(CNN) — Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a flurry of commitments to build or expand US manufacturing operations in the coming years.

AstraZeneca is investing $50 billion to expand its drug manufacturing in the US. Johnson & Johnson is pouring $55 billion into domestic production and research. And Eli Lilly said it will spend $27 billion to build four new manufacturing plants here.

In total, the planned investments exceed $250 billion, according to two industry analysts.

Trump is wielding the threat of tariffs to get drugmakers to increase their domestic production, which he says will strengthen national security . He’s also pushing pharmaceutical companies to reduce their pri